Couple things to respond:
Amy, Abiraterone is showing promise. I hope you draw the drug and not the placebo. My friend drew the placebo and had to opt out as his PSA continued a climb. The good news is that for every 3 people in the study 2 will get the drug and 1 the placebo.
Don, Most oncologists are not in favor of adjuvant chemotherapy with Taxotere. But that's what the study is about
. With 3 to 19 months life extension as a salvage treatment, they are hoping to prove is more in the multi-years catagory as an immediate follow up to post prostatectomy high risk cases before relapse.
Having known a quite a few guys who were treated with Taxotere, I have learned that attitude helps when taking on chemotherapy. There is a degradation in QoL but many of the guys have fought through and done well and had good QoL with it. In the few guys I know that took on Taxotere right after surgery, they handled it better than those who went through the meriad of treatments that eventually failed. This I believe is because those treatments have there own long term side effects. There is much to be said for the possibility that early Taxotere is better than later Taxotere.
The available studies are trying to prove this. My oncologist believes that it is quite possible because he has already administere adjuvant chemotherapy and the early results have been strong.
Age 46 (44 when Dx)
Pre-op PSA was 19.8 : Surgery at The City of Hope on February 16, 2007
Geason 4+3=7, Stage pT3b, N0, Mx
Positive Margins (PM), Extra Prostatic Extension (EPE) : Bilateral Seminal vesicle invasion (SVI)
HT began in May, '07 with Lupron and Casodex 50mg (2 Year ADT)
IMRT radiation for 38 Treatments ending August 3, '07
Current PSA (January 13, 2009): <0.1
My Journal is at Tony's Blog
My InfoLink page is at Tony's Prostate Cancer InfoLink Page
Post Edited (TC-LasVegas) : 4/10/2009 11:06:09 AM (GMT-6)